The article is devoted to the analysis of statistical data provided by the Committee of Automakers of the Association of European Businesses (AEB) on the volume of sales of passenger cars of various brands on the market of the Republic of Korea from 2010 to 2021. The article describes the history and current trends of the market in question. Moreover, the authors summarize previously conducted research on this topic, providing a list of relevant studies. By using the competitive analysis tool — SV matrix, the study aims to provide information of scientific importance on the subject of competitive environment within the market under consideration, as well as to identify leading companies. An interpretation based on the results of the study is presented as well. It includes an explanation of the dynamics in the market, including changes in the market share of companies within the selected time period, a description of the specificities of the modern market leaders development and the reasons for the existing competitive environment. The conclusion is made about the relative stability of the South Korean automobile market, which has a national manufacturer and retailer as a market leader throughout the analyzed period. Moreover, quite a reasonable assumption is made about the relevance of the development pattern of the South Korean automobile market for the corresponding market of the Russian Federation.

Introduction. Amid reports of a growing number of diabetic patients, the antidiabetics market players positioning is highly important for companies and the country’s leadership. The regulatory measures and management decisions depend on the competitive situation in the market.Aim. Analysis of the changes in the level of dominance on the markets for antidiabetics and blood glucose monitors and meters.Materials and methods. The distribution of these markets by product groups, as well as by commercial and public procurement segments has been taken into account. The Herfindahl-Hirschman and Linda indices, the adjusted Hall-Tideman index, concentration ratios and the SV matrix (strength/variety) were used as analysis tools, and the calculations were made on the basis of IQVIA data for the period from 2004 to the 3rd quarter of 2022.Results. The dominance of three foreign companies that fell into the B4 and G quadrants was detected in the insulin and insulin analogues market. The glucose-lowering drugs market is the most competitive, it fell into the RO quadrant more often than other markets, and the dominant group, depending on the segment, included foreign and domestic companies with different frequency. The dominance of both three foreign and one Russian companies in the B4 and G quadrants, as well as a larger number of companies, was identified in the market for other alimentary tract and metabolism products. Several foreign and one Russian company that were identified into the B4 and G quadrants steadily dominated in the markets for blood glucose test strips, glucose monitors and meters and accessories, and lancets.Conclusions. The antidiabetics market is highly concentrated in its segments. The results show the historical development of the studied markets, the role of the commercial and public procurement segments in them, and serve as the foundation for studying the impact of environmental events on the Russian antidiabetics market.

The article presents an analysis of development trends, as well as the dynamics of dominance and competition among drug manufacturers, distributors, and pharmacy chains in the Russian pharmaceutical market. The authors analyzed the mergers and acquisitions that took place in the pharmaceutical market, as well as data on the shares of leading companies in each market segment from 2004 to 2021 to identify dominance and determine the level of differentiation in the dominant groups. The Linda and Herfindahl-Hirschman indices, as well as the SV matrix (strength/variety) and concentration coefficients were used as analysis tools. In the market of drug manufacturers, both domestic and foreign companies have significant obstacles to consolidating and increasing their share. In this regard, the dominance of manufacturers in the market was not found. The distributor market, which had been in a state of “natural oligopoly” for a long time (B4 quadrant), turned into a “red ocean” state (RO quadrant) due to the loss of aggregate market share by the dominant group. The pharmacy chain market, on the contrary, has consolidated, and in the last four years a dominant group has appeared on it, and now the market is moving from the “red ocean” state (RO quadrant) to the “natural oligopoly” (B4 quadrant). Major players such as the multi-gamma alpha company ASNA, the IRIS partner- ship, and the interconnected networks resulting from mergers and acquisitions began to stand out. The results of the analysis indicate an increase in the importance of pharmacy chains against the background of a deterioration in the positions of distributors, and also reflect the development trends of the pharmaceutical market.